Praxis Precision Medicines Inc (PRAX) stock news · $7.38B cap
Praxis Precision Medicines Inc (PRAX) is a biotechnology company listed on US.
This PRAX news page leads with what Praxis Precision Medicines Inc filed — not a scraped headline mill.
No cached 8-K sentence for PRAX yet. We will not pad this page with generic market recap.
Latest reported PRAX revenue for 2025-12-31 was $0. Net income was -$303.3M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. PRAX currently screens at market cap $7.38B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the PRAX stock page; for the tape open the quote page.
PRAX stock news FAQ
What is PRAX's latest net income?
Latest cached Praxis Precision Medicines Inc (PRAX) net income was -$303.3M. Statements: https://lician.com/financials/prax
What is PRAX's market cap?
Praxis Precision Medicines Inc (PRAX) market cap is $7.38B on the latest cached fundamentals snapshot.
What kind of company is PRAX?
Praxis Precision Medicines Inc (PRAX) is a biotechnology company listed on US.
Where is PRAX stock news listed?
Cached stock news for Praxis Precision Medicines Inc (PRAX) is listed at https://lician.com/news/prax. Filings: https://lician.com/sec/prax
Not investment advice.